Search

everythinglearnresearchcommunity

for

Search:↓

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Balding and low testosterone increase risk of urinary stones.

Many products for hair re-growth exist, but a perfect treatment without side effects has not yet been found.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Gene mutations can cause problems in male genital development.

Adult hair follicle cells can create new hair follicles from corneal cells with the right support.

Medical treatments like chemotherapy and radiotherapy can harm sperm production, so freezing sperm before treatment is important for men who want children later.

Certain maturity signs appear before and after the first release of sperm in boys.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Cells from balding scalps have more androgen receptors than cells from non-balding scalps.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Finasteride can cause lasting sexual, emotional, and cognitive issues, with varying severity.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

New treatments for male hypogonadism are effective and should be personalized.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Some parents have a mild form of congenital adrenal hyperplasia without symptoms, and they usually don't need treatment.

Spironolactone can reduce hair growth in women with hirsutism.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

Men with Kennedy disease have less chance of hair loss.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

High doses of finasteride cause cell growth and tumors in mice.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.